Abate Kristin sold KPTI
October 1, 2026 · Form 4 insider transaction
Abate Kristin sold 378 shares of Karyopharm Therapeutics Inc. at $1.19 per share, a transaction worth $449.82. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
378
Price
$1.19
Total value
$449.82
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after23,404
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.